The development of activatable lytic peptides for targeting triple negative breast cancer

Cytolytic peptides are an emerging class of promising cancer therapeutics shown to overcome drug resistance. They eliminate cancer cells via disruption of the phospholipid bilayer of cell membranes, a mechanism that differentiates it from traditional treatments. However, applications of lytic peptid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell Death Discov
Hauptverfasser: Zhao, Hui, Qin, Xuan, Yang, Dan, Jiang, Yanhong, Zheng, Weihao, Wang, Dongyuan, Tian, Yuan, Liu, Qisong, Xu, Naihan, Li, Zigang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5629628/
https://ncbi.nlm.nih.gov/pubmed/29263848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2017.37
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge